Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial

Subjects

Subjects :

Hematology

Details

ISSN :

23523026

Database :

OpenAIRE

Journal :

The Lancet Haematology

Accession number :

edsair.doi...........6079021cd59517ed46220c7a65f07429

Full Text :

https://doi.org/10.1016/s2352-3026(23)00073-x